Pediatric Thyroid Cancer: genetics, Therapeutics and Outcome

• Autores: Andrew J. Bauer
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 49, Nº. 4, 2020 (Ejemplar dedicado a: Pediatric Endocrinology), págs. 589-611
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • An increasing number of children are diagnosed with thyroid cancer. Most patients do not have an identifiable cause; however, tumor predisposition syndromes may be associated with development of both differentiated and medullary thyroid cancer. With an excellent prognosis for most patients, the goal of therapy is to optimize outcome and reduce complications. The increased knowledge of the oncogenic drivers provides opportunities to improve the accuracy of diagnosis, stratify surgery, and select systemic therapy that may be considered for neoadjuvant and adjuvant treatment. Treatment complications can be reduced by referral to regional, high-volume pediatric thyroid centers.